All In MedTech

Device Trial Radar · NCT02447133

TopQ Cut-off Score Validation Study for 3D OCT-1 Maestro

Last checked: Nov 19, 2026Latest source record: Jun 29, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

12

Actual

Start

May 2015

Primary completion

May 2015

Study completion May 2015

Sponsor

Lead sponsor
Topcon Medical Systems, Inc.Not on our public-company list
Sponsor type
Industry
First posted
May 18, 2015

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The objective of this study is to validate the TopQ cutoff scores, which have been previously determined.

Conditions

  • Subjects Presenting With Normal Eyes

Interventions

  • 3D OCT-1 MaestroDevice

    OCT Machine used for diagnostic purposes

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. TopQ Cut OffTime frame: 1 hour

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Topcon Medical Systems, Inc.

    Oakland, New Jersey

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.